Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and apparatus for photoactivation medicament treatment

A photoactivation, drug technology, applied in phototherapy, treatment, pharmaceutical formulations, etc., can solve problems such as increasing the risk of rupture, and achieve the effect of low risk of complications and low cost

Active Publication Date: 2009-04-08
EURO-CELTIQUE SA
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The maximum diameter of the light bar is limited by human anatomy, while the minimum diameter is limited by the following factors: the size of the light generator that emits the desired wavelength or band of light at a sufficient energy level; Fragile, which increases the risk of rupture in the patient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and apparatus for photoactivation medicament treatment
  • Method and apparatus for photoactivation medicament treatment
  • Method and apparatus for photoactivation medicament treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] In the following description, certain specific details are set forth in order to provide a thorough understanding of various embodiments of the invention. One skilled in the art will recognize, however, that the invention may be practiced without one or more of these specific details, or with other methods, components, materials, or the like. In other instances, well-known structures related to light sources, catheters, and / or treatment devices have not been specifically shown or described in order to avoid unnecessarily obscuring descriptions of embodiments of the invention.

[0031] In general, a prostate treatment system may include a transurethral treatment device having a light delivery device within or along an elongate support for the treatment of benign prostatic hyperplasia (BPH) or other prostate conditions. In one embodiment, the therapeutic device includes a light delivery device disposed on the surface of the elongate support, or in other embodiments, the l...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A prostate treatment system having a light delivery device positionable in a transurethral device for treatment of benign prostatic hyperplasia (BPH). The light delivery device includes light generator, such as light emitting diodes (LED), laser diodes (LDs) or a diffusion quartz fiber tip connected to a light generator or a light emitting polymer which produces light at a selected wavelength or waveband or alternative sources of suitable light energy. The treatment device may further include a temperature monitoring system for monitoring the temperature at the treatment site. A light-activated drug is administered to the treatment site prior to light activation. The light-activated drug therapy induces cell death of the target tissue. The device provides a minimally invasive transurethral method for treatment of BPH or prostate cancer.

Description

technical field [0001] The present invention relates generally to prostate treatment systems for use in the treatment of prostate tissue in combination with photoactive agents, and more particularly to transurethral devices for use in the treatment of benign prostatic hyperplasia (BPH) in combination with photoactivatable drugs. Background technique [0002] Benign prostatic hyperplasia (BPH) and prostate cancer are common conditions among older men. In people with BPH, an enlarged prostate can press on the urethra causing urinary tract obstruction, which makes urination difficult. An enlarged prostate can also cause stones in the urethra, inflammation, infection, and in some cases, kidney failure. [0003] Primary treatments for BPH include surgical procedures such as prostatectomy or transurethral resection of the prostate. These treatments require the patient to be hospitalized, which can be a financial burden for the patient. Furthermore, the surgical procedure can le...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61B18/18
CPCA61N2005/0652A61B2017/00084A61N5/0601A61B2017/22068A61N5/062A61N2005/061A61B2017/00274A61B2018/00547A61B2018/00285A61B2018/00821A61B2018/2261A61N5/0603A61N2005/0602A61N2005/063A61N5/067A61K41/0071
Inventor L·凯尔特纳J·温希普S·E·哈格斯特伦F·郑J·C·陈J·M·霍比斯
Owner EURO-CELTIQUE SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products